Literature DB >> 21398269

Palliative dialysis in end-stage renal disease.

Disha D Trivedi1.   

Abstract

Dialysis patients are often denied hospice benefits unless they forego dialysis treatments. However, many of those patients might benefit from as-needed dialysis treatments to palliate symptoms of uremia, fluid overload, etc. The current Medicare payment system precludes this "palliative dialysis" except in those few cases where the terminal diagnosis is unrelated to renal failure. As approximately three quarters of all US patients on dialysis have Medicare as their primary insurance, a of review of Medicare policy is suggested, with a goal of creating a new "palliative dialysis" category that would allow patients to receive treatments on a less regular schedule without affecting the quality statistics of the dialysis center.( 1 ).

Entities:  

Mesh:

Year:  2011        PMID: 21398269     DOI: 10.1177/1049909111400061

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  3 in total

Review 1.  Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients.

Authors:  Charles Chazot; Ken Farrington; Ionut Nistor; Wim Van Biesen; Hanneke Joosten; Daniel Teta; Dimitrie Siriopol; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

2.  A palliative approach to dialysis care: a patient-centered transition to the end of life.

Authors:  Vanessa Grubbs; Alvin H Moss; Lewis M Cohen; Michael J Fischer; Michael J Germain; S Vanita Jassal; Jeffrey Perl; Daniel E Weiner; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-07       Impact factor: 8.237

3.  Clinical Impact of Education Provision on Determining Advance Care Planning Decisions among End Stage Renal Disease Patients Receiving Regular Hemodialysis in University Malaya Medical Centre.

Authors:  Albert Hing Wong; Loh Ee Chin; Tan Li Ping; Ng Kok Peng; Lim Soo Kun
Journal:  Indian J Palliat Care       Date:  2016 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.